Meet SI-BONE | Company Overview | SI-BONE


Advancing the diagnostic understanding of the sacroiliac joint and minimally invasive surgery for certain causes of SI joint disorders.


Faits saillants

SI-BONE is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Published clinical studies have shown that 15% to 30% of chronic lower back pain is associated with the sacroiliac (SI) joint. In 2009, SI-BONE pioneered a proprietary minimally invasive surgical system, the iFuse Implant System®, to fuse the SI joint and treat SI joint dysfunction. Tens of thousands of patients have subsequently been treated with iFuse by thousands of trained surgeons around the world.

SI-BONE has more recently expanded its iFuse Technology® platform to include iFuse-3D™ and has cleared indications in pelvic trauma and adult spinal deformity.

SI-BONE is focused on helping patients in one of the most under-served, under-diagnosed, and under-treated areas in orthopedics, the sacroiliac (SI) joint. The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. The iFuse Implant System is also intended for sacroiliac fusion to augment immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as a part of a lumbar or thoracolumbar fusion.

3,000+Treating Surgeons

75,000+iFuse Procedures Performed

100+iFuse Publications

Vous avez des questions?

Nous pouvons vous aider. Dites-nous ce que vous recherchez ci-dessous.